NCT02438514

Brief Summary

The investigators propose to evaluate the potential utility of stress-related biomarkers obtained via dried blood spots (DBS) and retinal scans by collecting new data from mothers and children within the New Haven MOMS Partnership, a well-established community-partnered research setting. The proposed research could greatly advance the application of stress-related biomarkers within community-based research by increasing our understanding of how stress, trauma, and depression influence biology in childhood and adulthood, as measured using minimally-invasive approaches.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 29, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 8, 2015

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

March 12, 2020

Status Verified

March 1, 2020

Enrollment Period

4.2 years

First QC Date

April 29, 2015

Last Update Submit

March 11, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Number of Mother-Child Dyads Who Complete Assessments & Biological Samples

    Feasibility outcome

    End of study (approximately 5 years)

  • Telomere Length

    Telomere length will be measured using an adapted method of the Cawthon Telomere Assay

    At baseline-After 90 minutes

  • Advanced Glycation End Products (AGEs)

    AGEs or (advanced glycation endproducts) will be measured using a painless non- invasive retinal scanning device that measures autofluorescence of the crystalline lens of the eye

    At baseline-After 90 minutes

Interventions

Anthropomorphic biomarkers including height, weight, heart rate, and blood pressure will be taken for each participating mother and child by a research assistant trained to accurately perform these procedures. Blood spots will be collected in finger stick proficiency, using trigger activated lancets to administer finger sticks. Each participating mothers and child will provide a saliva sample using Oragene DNA saliva collection kits

Eligibility Criteria

Age21 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Low-income, racially and ethnically diverse, un- or under-employed, biological mothers of children in New Haven. Primary source of recruitment will be the screening/needs assessment from our affiliated MOMS Partnership protocol, however, we will actively respond to inquiries from any preliminarily eligible biological mother in the New Haven community who expresses interest in the study

You may qualify if:

  • English-speaking adult mothers (age 21 or older) of at least one biological child mothers must be able to answer three verification questions to confirm they are the biological parent of their child

You may not qualify if:

  • Non-english speakers
  • Women not able to provide informed consent and with no biological children
  • Mothers under the age of 21

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale University

New Haven, Connecticut, United States

Location

MeSH Terms

Conditions

Stress, Psychological

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2015

First Posted

May 8, 2015

Study Start

November 1, 2014

Primary Completion

January 1, 2019

Study Completion

November 1, 2019

Last Updated

March 12, 2020

Record last verified: 2020-03

Locations